KRRO (korrobio.com) Quarterly EPS earnings growth

Brandmark of Korro Bio (KRRO)

Korro Bio, Inc. (KRRO) combines the licensing potential of a universal RNA editing core with a current lack of operating profit due to its venture stage of development. The quarterly EPS growth trend clearly illustrates the profit dynamics, where the value of 48.70 characterizes this level. The high scalability of the technological base will provide the company with colossal revenues at minimal production costs in the future.

Korro Bio Inc. (KRRO) Earnings per share growth in annualized terms for the last twelve months: for the period 02/21/2024 - 11/13/2026

Summary analytical data breakdowns for Korro Bio, Inc. (KRRO)

- share price and expert price forecast:
Stock Price korrobio.com|KRRO - Price Target Chart
- business market valuation indicators:
Market Capitalization Korro Bio, Inc|KRRO - Company Buyout Price
- balance sheet net asset value indicators:
Net Assets per Single Share Korro Bio|KRRO - Total Stockholders' Equity|Market Cap to Net Assets Ratio korrobio.com|KRRO - Aggregate Asset Value
- debt level and financial liquidity data:
Total Debt to Capital Korro Bio, Inc.|KRRO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity korrobio.com|KRRO - Company Aggregate Debt|Debts to Book Capitalization Korro Bio, Inc|KRRO - Company Long-Term Liabilities|Company Current Liabilities Korro Bio|Quick Liquidity korrobio.com
- earnings and market multiples details:
KRRO - Net Profit|Expected Profit Korro Bio, Inc.|KRRO - Company Value to Net Income|Future Price to Earnings korrobio.com|KRRO - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Korro Bio, Inc|KRRO - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Korro Bio|KRRO - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months korrobio.com|KRRO - Earnings per share growth this year|Earnings growth forecast for next year Korro Bio, Inc.
Summary company analysis:Korro Bio Inc. - KRRO
Flagship merchandise of korrobio.com

Assessing business resilience to crises requires an analysis of net income per share dynamics. Korro Bio, Inc. (KRRO) is developing a unique RNA editing platform, which minimizes the impact of price competition. This quarterly growth in earnings per share measures the rate of change in profitability, revealing hidden increases in operating expenses. Analyzing this metric allows for the determination of the risk of a deep drawdown when purchasing the asset at its peak. The investor gains a tool for verifying the financial security of the investment.

Main competitors

TEM: Quarterly EPS earnings growth|QGEN (Qiagen NV) - Year-over-year earnings per share growth for the last twelve months|IONS (Ionis Pharma) - Quarterly EPS earnings growth|Repligen Inc. (RGEN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Avidity Biosciences (RNA)|CRSP - Earnings per share growth in annualized terms for the last twelve months|GeneDx - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months RARE|Beam Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Sarepta Corp SRPT|Twist Bioscience (TWST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months TXG|NTLA (Intellia Therapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Stoke Therapeutics Inc (STOK)|Year-over-year net earnings per share growth for the last 12 months BLFS (BioLife Corp)|Year-over-year net earnings per share change for the last twelve months Wave Pharma|Year-over-year earnings per share growth for the last twelve months Maze Therapeutics Inc MAZE|Quarterly EPS earnings growth sionnatx.com SION|PRME - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha Gene Therapies Inc)|uniQure Corp (QURE) - Year-over-year earnings per share growth for the last twelve months|MeiraGTx Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months REGENXBIO Inc.|Earnings per share growth in annualized terms for the last twelve months solidbio.com SLDB|Quarterly EPS earnings growth OCGN|Pacific Biosciences of California, Inc. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Benitec BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|Rocket Pharmaceuticals - Quarterly EPS earnings growth|FDMT - Quarterly EPS earnings growth|lexeotx.com (LXEO) - Year-over-year earnings per share growth for the last twelve months|Editas Medicine Inc (EDIT) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Silence Therapeutics Inc.|Earnings per share growth in annualized terms for the last twelve months ProQR Therapeutics NV PRQR|Year-over-year earnings per share growth for the last twelve months Codexis, Inc. (CDXS)|SGMO (sangamo.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Nautilus Bio NAUT|Year-over-year earnings per one share growth for the last 12 months MGX|DTIL - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Generation Bio Co.|BOLD (Boundless Bio, Inc.) - Year-over-year net earnings per share growth for the last 12 months|Exicure - Year-over-year earnings per one share growth for the last 12 months|IMNN (Imunon Inc) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months PHIO|Quarterly EPS earnings growth MBIO|Year-over-year net earnings per share change for the last twelve months transcodetherapeutics.com|Year-over-year earnings per share growth for the last twelve months Bionano Genomics BNGO|adnas.com (APDN) - Earnings per share growth in annualized terms for the last twelve months|BLUE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months IPA (ImmunoPrecise Antibodies)|OMGA: Quarterly EPS earnings growth|OMIC - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Regulus Therapeutics|Year-over-year earnings per share growth for the last 12 months SYRS (syros.com)|Quarterly EPS earnings growth TBIO|Year-over-year net earnings per share growth for the last 12 months TRACON Pharmaceuticals Inc. TCON|Unity Bio - Year-over-year net earnings per share growth for the last 12 months